Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs TKO Group Holdings Inc (TKO) Price & Performance

Novo Nordisk A/STrade
TKO Group Holdings IncTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs TKO Group Holdings Inc — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while TKO Group Holdings Inc trades at $181.83 (market cap $13.70B). The key difference: Novo Nordisk A/S is far larger — about 16.1× TKO Group Holdings Inc's market cap, and Novo Nordisk A/S pays the higher dividend (3.63%). Which is the better fit depends on your goals.

NVOTKO
Market Cap
$220.53B$13.70B
Sector
HealthTechnology
52-Week High
$71.70$224.96
52-Week Low
$35.29$155.61
Enterprise Value
$239.49B$17.88B
Dividend Yield
3.63%1.7%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About TKO Group Holdings Inc

TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.

Read more on TKO